BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The inaugural ADC Target Selection Summit developed in collabo
 ration with AstraZeneca\, AbbVie\, Mersana and Eisai is the industry’s de
 finitive conference dedicated to exploring the importance of ADC target s
 election\, discussing the validation of novel targets\, understanding the
  patient population for a certain target and therefore developing life-ch
 anging ADCs.\n\nJoin your peers within target discovery from large pharma
 \, innovative biotech and research institutes to discuss key challenges i
 ncluding the target-payload pairing and ensuring that it’s right from the
  get-go\, differentiating solid tumors and hematological cancer targets a
 nd assessing the antibody for small molecule target validation.\n\nAs par
 t of the World ADC Series this virtual meeting is the go-to for scientist
 s involved within target selection\, cancer biology and bioinformatics. B
 e part of this focused discussion as 20+ world class experts define the c
 riteria of what makes a good target so that you can elevate your company’
 s target selection strategy to create successful ADCs and accelerate more
  solid tumor targeting ADCs into the clinic.\n
DTEND:20211208T163000
DTSTAMP:20260512T234653Z
DTSTART:20211206T110000
LOCATION:Online\, \,
SEQUENCE:0
SUMMARY:The inaugural ADC Target Selection Summit developed in collaborati
 on with AstraZeneca\, AbbVie\, Mersana and Eisai is the industry’s defini
 tive confe...
UID:dc06427d-4b52-4d63-93c6-d6a82c661a11
END:VEVENT
END:VCALENDAR